![PDF) Autologous stem cell transplantation in refractory Crohn's disease - Low intensity therapy evaluation (ASTIClite): Study protocols for a multicentre, randomised controlled trial and observational follow up study PDF) Autologous stem cell transplantation in refractory Crohn's disease - Low intensity therapy evaluation (ASTIClite): Study protocols for a multicentre, randomised controlled trial and observational follow up study](https://i1.rgstatic.net/publication/333527161_Autologous_stem_cell_transplantation_in_refractory_Crohn's_disease_-_Low_intensity_therapy_evaluation_ASTIClite_Study_protocols_for_a_multicentre_randomised_controlled_trial_and_observational_follow_u/links/5cf1f189299bf1fb184e84f3/largepreview.png)
PDF) Autologous stem cell transplantation in refractory Crohn's disease - Low intensity therapy evaluation (ASTIClite): Study protocols for a multicentre, randomised controlled trial and observational follow up study
![PDF) Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors PDF) Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors](https://i1.rgstatic.net/publication/335436307_Death_after_hematopoietic_stem_cell_transplantation_changes_over_calendar_year_time_infections_and_associated_factors/links/5d65d35e299bf1f70b124199/largepreview.png)
PDF) Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors
![Why are there regional differences in stem cell transplantation activity? An EBMT analysis | Bone Marrow Transplantation Why are there regional differences in stem cell transplantation activity? An EBMT analysis | Bone Marrow Transplantation](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fbmt.2008.104/MediaObjects/41409_2008_Article_BFbmt2008104_Fig1_HTML.jpg)
Why are there regional differences in stem cell transplantation activity? An EBMT analysis | Bone Marrow Transplantation
![Cancers | Free Full-Text | Immunotherapy for Diffuse Large B-Cell Lymphoma: Current Landscape and Future Directions Cancers | Free Full-Text | Immunotherapy for Diffuse Large B-Cell Lymphoma: Current Landscape and Future Directions](https://pub.mdpi-res.com/cancers/cancers-13-05827/article_deploy/html/images/cancers-13-05827-g001.png?1637403045)
Cancers | Free Full-Text | Immunotherapy for Diffuse Large B-Cell Lymphoma: Current Landscape and Future Directions
![Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41409-019-0718-7/MediaObjects/41409_2019_718_Fig5_HTML.png)
Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and
![View of Use of a maturity model for facilitating the introduction of CAR T-cell therapy—Results of the START CAR-T project | Global & Regional Health Technology Assessment View of Use of a maturity model for facilitating the introduction of CAR T-cell therapy—Results of the START CAR-T project | Global & Regional Health Technology Assessment](https://journals.aboutscience.eu/index.php/grhta/article/download/2340/2522/9010/img04.png)
View of Use of a maturity model for facilitating the introduction of CAR T-cell therapy—Results of the START CAR-T project | Global & Regional Health Technology Assessment
![PDF) Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) PDF) Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT)](https://i1.rgstatic.net/publication/336712884_Benchmarking_of_survival_outcomes_following_haematopoietic_stem_cell_transplantation_A_review_of_existing_processes_and_the_introduction_of_an_international_system_from_the_European_Society_for_Blood_/links/5daeb2eb299bf111d4bfa849/largepreview.png)
PDF) Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT)
![View of Use of a maturity model for facilitating the introduction of CAR T-cell therapy—Results of the START CAR-T project | Global & Regional Health Technology Assessment View of Use of a maturity model for facilitating the introduction of CAR T-cell therapy—Results of the START CAR-T project | Global & Regional Health Technology Assessment](https://journals.aboutscience.eu/index.php/grhta/article/download/2340/2522/9008/img02.png)
View of Use of a maturity model for facilitating the introduction of CAR T-cell therapy—Results of the START CAR-T project | Global & Regional Health Technology Assessment
![Cells | Free Full-Text | Cellular-Based Therapies in Systemic Sclerosis: From Hematopoietic Stem Cell Transplant to Innovative Approaches Cells | Free Full-Text | Cellular-Based Therapies in Systemic Sclerosis: From Hematopoietic Stem Cell Transplant to Innovative Approaches](https://pub.mdpi-res.com/cells/cells-11-03346/article_deploy/html/images/cells-11-03346-g001.png?1666608384)